Loading…
Early Hearing Detection and Intervention Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
93pct
217d open
vs 3,805 other S bills in the 115th — cohort avg 41d
(This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.) Early Hearing Detection and Intervention Act of 2017 (Sec. 2) This bill amends the Public Health Service Act to revise programs for deaf and hard-of-hearing newborns and infants, including to expand the programs to include young children. The programs are reauthorized through FY2022. Health Resources and Services Administration support for the education and training of personnel and health care providers for such programs is expanded to include education and training of family members.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2018 · fourth_quarter · Budget/Appropriations
H.R. 1892, the "Bipartisan Budget Act of 2018," provisions related to healthcare. Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). Coalition letter to members of U.S. House Committee on Appropriations regarding funding for universal newborn hearing screening programs, as authorized by H.R.1539/S.652 the "Early Hearing Detection and Intervention (EHDI) Act of 2017." Coalition letter to U.S. Senate Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. Coalition letter to U.S. House Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. Coalition letter to U.S. House and Senate Conferees regarding H.R. 6147, urging the conferees to reject all tobacco riders that would weaken FDA oversight of tobacco products, including e-cigarettes and cigars. FY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 6147); provisions related to Tobacco Policy Riders. Coalition letter to leaders of the U.S. House Appropriations Committee requesting funding for the Agency for Healthcare Research and Quality (AHRQ) at a level equal to or higher than the House and Senate marks. Coalition letter to leaders of the U.S. Senate Appropriations Committee requesting funding for the Agency for Healthcare Research and Quality (AHRQ) at a level equal to or higher than the House and Senate marks.
Became Public Law No: 115-71.
Became Public Law No: 115-71.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H7694-7696)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H7694-7696)
DEBATE - The House proceeded with forty minutes of debate on S. 652.
Considered under suspension of the rules. (consideration: CR H7694-7698)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2018 · third_quarter · Budget/Appropriations
H.R. 1892, the "Bipartisan Budget Act of 2018," provisions related to healthcare. Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). Coalition letter to members of U.S. House Committee on Appropriations regarding funding for universal newborn hearing screening programs, as authorized by H.R.1539/S.652 the "Early Hearing Detection and Intervention (EHDI) Act of 2017." Coalition letter to U.S. Senate Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. Coalition letter to U.S. House Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. Coalition letter to U.S. House and Senate Conferees regarding H.R. 6147, urging the conferees to reject all tobacco riders that would weaken FDA oversight of tobacco products, including e-cigarettes and cigars. FY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 6147); provisions related to Tobacco Policy Riders. Coalition letter to leaders of the U.S. House Appropriations Committee requesting funding for the Agency for Healthcare Research and Quality (AHRQ) at a level equal to or higher than the House and Senate marks. Coalition letter to leaders of the U.S. Senate Appropriations Committee requesting funding for the Agency for Healthcare Research and Quality (AHRQ) at a level equal to or higher than the House and Senate marks.
Client expense: $200,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE
2018 · second_quarter · Budget/Appropriations
H.R. 1892, the "Bipartisan Budget Act of 2018," provisions related to healthcare. Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). Coalition letter to members of U.S. House Committee on Appropriations regarding funding for universal newborn hearing screening programs, as authorized by H.R.1539/S.652 the "Early Hearing Detection and Intervention (EHDI) Act of 2017." Coalition letter to U.S. Senate Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. Coalition letter to U.S. House Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill.
Client expense: $190,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE
2018 · first_quarter · Budget/Appropriations
H.R. 1892, the "Bipartisan Budget Act of 2018," provisions related to healthcare. Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). Coalition letter to members of U.S. House Committee on Appropriations regarding funding for universal newborn hearing screening programs, as authorized by H.R.1539/S.652 the "Early Hearing Detection and Intervention (EHDI) Act of 2017."
Client expense: $160,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE
2017 · fourth_quarter · Budget/Appropriations
Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). H.R. 1539/S. 652, the "Early Hearing Detection and Intervention Act of 2017," all provisions. Agency for Healthcare Research and Quality (AHRQ) funding request(s) for FY2017. Support for funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) in the FY 2018 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill. Support for authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products in the FY 2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill, and opposition to any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Opposition to Sections 752 and 753 of the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2018. These sections weaken the Food and Drug Administrations (FDA) May 2016 final rule that gives the agency authority to oversee cigars, e-cigarettes, and certain other tobacco products. Opposition to Rep. James Comers amendment (amendment #9) to Division B of H.R. 3354, the Make America Secure and Prosperous Appropriations Act, which would prohibit the Food and Drug Administration (FDA) from finalizing a product standard to reduce N-Nitrosonornicotine (or NNN), a carcinogen in smokeless tobacco products. For FY18, opposition to the inclusion of either of two policy riders originally included in the House Appropriations Committees Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill that would weaken FDAs authority to oversee tobacco products. Opposition to the House Appropriations Committees proposed 25% cut to the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH).
Client expense: $190,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2017 · third_quarter · Budget/Appropriations
Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). H.R. 1539/S. 652, the "Early Hearing Detection and Intervention Act of 2017," all provisions. Agency for Healthcare Research and Quality (AHRQ) funding request(s) for FY2017. Support for funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) in the FY 2018 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill. Support for authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products in the FY 2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill, and opposition to any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA). Opposition to Sections 752 and 753 of the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2018. These sections weaken the Food and Drug Administrations (FDA) May 2016 final rule that gives the agency authority to oversee cigars, e-cigarettes, and certain other tobacco products. Opposition to Rep. James Comers amendment (amendment #9) to Division B of H.R. 3354, the Make America Secure and Prosperous Appropriations Act, which would prohibit the Food and Drug Administration (FDA) from finalizing a product standard to reduce N-Nitrosonornicotine (or NNN), a carcinogen in smokeless tobacco products.
Client expense: $200,000 · Firm income: Not reported
2017 · second_quarter · Budget/Appropriations
Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). H.R. 1539/S. 652, the "Early Hearing Detection and Intervention Act of 2017," all provisions. Agency for Healthcare Research and Quality (AHRQ) funding request(s) for FY2017. Support for funding for the Centers for Disease Control and Preventions (CDC) Office on Smoking and Health (OSH) in the FY 2018 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill. Support for authorized level of user fees for the Food and Drug Administrations (FDA) oversight of tobacco products in the FY 2018 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill, and opposition to any effort to limit the authority that Congress granted the FDA under the Family Smoking Prevention and Tobacco Control Act (TCA).
Client expense: $210,000 · Firm income: Not reported
2017 · first_quarter · Budget/Appropriations
Opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA). H.R. 1539/S. 652, the "Early Hearing Detection and Intervention Act of 2017," all provisions. Agency for Healthcare Research and Quality (AHRQ) funding request(s) for FY2017.
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE, Treasury, Dept of
2017 · first_quarter · Health Issues
S.670 and H.R. 1652, Over the Counter (OTC) Hearing Aid Act - provided input to this legislation which would allow the sale of OTC hearing aids to consumers with mild to moderate hearing loss. S. 48, Hearing Aid Tax Credit, support for tax credit for hearing aids once every five years. H.R. 1539 and S. 652, support for legislation to reauthorize the Early Hearing Detection and Intervention Act to ensure early intervention services are received by children.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Mr. Burgess moved to suspend the rules and pass the bill.
Referred to the House Committee on Energy and Commerce.
Received in the House.
Message on Senate action sent to the House.
Passed Senate with an amendment by Unanimous Consent. (consideration: CR S5017-5018; text: CR S5017-5018)
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(consideration: CR S5017-5018; text: CR S5017-5018)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 44.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
| Senate |
| Referred to |
| March 15, 2017 |
| May 1, 2017 |
| Introduced in Senate | March 15, 2017 |
| Enrolled Bill | -- |
| Democratic |
| MA |
| John Boozman | Republican | AR |
| John Cornyn | Republican | TX |
| Lamar Alexander | Republican | TN |
| Patrick J. Leahy | Democratic | VT |
| Patty Murray | Democratic | WA |
| Richard Blumenthal | Democratic | CT |
| Sheldon Whitehouse | Democratic | RI |
| Sherrod Brown | Democratic | OH |
| Thad Cochran | Republican | MS |
| Tim Kaine | Democratic | VA |
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)